Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Alteplase

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Activacin

    02 5Activase/TNKase

    03 1Activase/Tnkase

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Activase/TNKase

    Alteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/TNKase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2019 Revenue in Millions : 1,372

    2018 Revenue in Millions : 1,323

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Activase/TNKase

    Alteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/TNKase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2020 Revenue in Millions : 1,472

    2019 Revenue in Millions : 1,484

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Activase/TNKase

    Alteplase/Tenecteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/TNKase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase/Tenecteplase

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 1,412

    2020 Revenue in Millions : 1,400

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Activase/TNKase

    Alteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/TNKase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 1,287

    2021 Revenue in Millions : 1,412

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Activase/TNKase

    Alteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/TNKase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 1,361

    2022 Revenue in Millions : 1,287

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Activacin

    Alteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activacin

    Japan
    arrow
    2024 ACI Convention
    Not Confirmed

    Kyowa Kirin

    Alteplase

    Main Therapeutic Indication : Neurological/Mental Disorders

    Currency : USD

    2018 Revenue in Millions : 10

    2017 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Activase/Tnkase

    Alteplase/Tenecteplase

    arrow
    2024 ACI Convention
    Not Confirmed

    Brand Name : Activase/Tnkase

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed

    Roche

    Alteplase/Tenecteplase

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2018 Revenue in Millions : 1,297

    2017 Revenue in Millions : 1,231

    Growth (%) : 5%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF